Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Conjunctivitis, Allergic

In brief

The purpose of this study is to evaluate whether bepotastine besilate ophthalmic solution is effective in the treatment of acute allergic conjunctivitis

Key facts

Study ID

NCT00424398

Run by

Bausch & Lomb Incorporated

People needed

107

Starts

2007-02-01

Last updated by the study team

2013-02-15

Who can join

Age: 10 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 10 years of age \& either sex, any race
• Willing and able to follow all instructions and attend all study visits
• Positive history of ocular allergies

You may not qualify if…

• Have planned surgery during trial period
• Female currently pregnant, planning a pregnancy, or lactating

Where it is running

• ISTA Pharmaceuticals, Inc. — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.